Seana Carson sold $65k of BHC
EVP, General Counsel at Bausch Health Companies Inc.. 11,276 shares at an average of $5.78, traded Mar 2, 2026, filed Mar 3, 2026.
Score components
- +15RoleOfficer
- +8Trade size$65k at market
- 0Share of holdings soldSold 1.4% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000885590-26-000039, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | FTax withholding Common Shares, No Par Value10b5-1 | -26,326 | $5.93 | $156k | 782,932 | Mar 3, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Shares, No Par Value10b5-1 | -6,856 | $5.78 | $40k | 776,076 | Mar 3, 2026 |
| Mar 2, 2026 | FTax withholding Common Shares, No Par Value10b5-1 | -16,973 | $5.95 | $101k | 759,103 | Mar 3, 2026 |
| Mar 2, 2026 | JOther Common Shares, No Par Value10b5-1 | -137,922 | $5.95 | $821k | 621,181 | Mar 3, 2026 |
| Mar 3, 2026 | SOpen-market sale Common Shares, No Par Value10b5-1 | -4,420 | $5.77 | $26k | 616,761 | Mar 3, 2026 |
Related signals
Other insiders at Bausch Health Companies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 2Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $50k 8,388 shares | -1% | |
| 36Weak | BHCbuy Bausch Health Companies Inc. | Paulson & Co. Inc. owner | $16M 2,500,000 shares | +4% | |
| 5Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $98k 13,370 shares | -3% | |
| 30Weak | BHCsell Bausch Health Companies Inc. | Frank D. Lee director | $122k 15,912 shares | -18% | |
| 59Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $312M 34,721,118 shares | +96% | |
| 56Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $21M 3,243,049 shares | +10% | |
| 56Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $21M 3,564,059 shares | +12% | |
| 51Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $15M 2,788,608 shares | +11% | |
| 0Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $3,674 440 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.